Nicola J Gray1, Karen L Shaw2, Felicity J Smith3, Jonathan Burton4, Julie Prescott5, Rachel Roberts6, David Terry7, Janet E McDonagh8. 1. Green Line Consulting Limited, Manchester, United Kingdom. Electronic address: nicola@greenlineconsulting.co.uk. 2. NIHR CLAHRC West Midlands, School of Health and Population Sciences, University of Birmingham, Birmingham, United Kingdom. 3. UCL School of Pharmacy, London, United Kingdom. 4. Right Medicine Pharmacy, University of Stirling, Stirling, United Kingdom. 5. School of Education and Psychology, University of Bolton, Bolton, United Kingdom. 6. Pharmacy Research UK, London, United Kingdom. 7. Pharmacy Academic Practice Unit, Aston University, Pharmacy Department, Birmingham Children's Hospital, Birmingham, United Kingdom. 8. Centre for Musculoskeletal Research and NIHR Manchester Musculoskeletal Biomedical Research Unit, University of Manchester, Manchester, United Kingdom.
Abstract
PURPOSE: To explore the perceived and potential roles of pharmacists in the care of young people aged 10-24 years with chronic illness, through the exemplar of juvenile arthritis, from the perspectives of UK community and hospital pharmacists, health service commissioners, rheumatology health professionals, and lay advocates. METHODS: A sequential mixed methods study design comprises the following: focus groups with community and hospital pharmacists; telephone interviews with pharmacy and rheumatology stakeholders and commissioners; and multidisciplinary group discussions to prioritize roles generated by the first two qualitative phases. RESULTS: The high priority roles for pharmacists, identified by pharmacists and rheumatology staff, were developing generic health care skills among young people; transferring information effectively across care interfaces; building trusting relationships with young people; helping young people to find credible online health information; and the need to develop specialist expertise. Participants identified associated challenges for pharmacists in supporting young people with chronic illness. These challenges included parents collecting prescription refills alone, thus reducing opportunities to engage, and pharmacist isolation from the wider health care team. CONCLUSIONS: This study has led to the identification of specific enhancements to pharmacy services for young people, which have received the endorsement of a wide range of stakeholders. These suggestions could inform the next steps in developing the contribution of community and hospital pharmacy to support young people with chronic illness in the optimal use of their medication.
PURPOSE: To explore the perceived and potential roles of pharmacists in the care of young people aged 10-24 years with chronic illness, through the exemplar of juvenile arthritis, from the perspectives of UK community and hospital pharmacists, health service commissioners, rheumatology health professionals, and lay advocates. METHODS: A sequential mixed methods study design comprises the following: focus groups with community and hospital pharmacists; telephone interviews with pharmacy and rheumatology stakeholders and commissioners; and multidisciplinary group discussions to prioritize roles generated by the first two qualitative phases. RESULTS: The high priority roles for pharmacists, identified by pharmacists and rheumatology staff, were developing generic health care skills among young people; transferring information effectively across care interfaces; building trusting relationships with young people; helping young people to find credible online health information; and the need to develop specialist expertise. Participants identified associated challenges for pharmacists in supporting young people with chronic illness. These challenges included parents collecting prescription refills alone, thus reducing opportunities to engage, and pharmacist isolation from the wider health care team. CONCLUSIONS: This study has led to the identification of specific enhancements to pharmacy services for young people, which have received the endorsement of a wide range of stakeholders. These suggestions could inform the next steps in developing the contribution of community and hospital pharmacy to support young people with chronic illness in the optimal use of their medication.